Amanote Research
Register
Sign In
397. IL-12 Increases Immune Responses Induced by a Novel pDNA Prostate Cancer Immunotherapy Approach in Non-Human Primates
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34732-3
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
IL-12 Immunotherapy of BrafV600E-induced Papillary Thyroid Cancer in a Mouse Model
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Improving Cancer Immunotherapy by Targeting Tumor-Induced Immune Suppression
Cancer and Metastasis Reviews
Cancer Research
Oncology
Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy
Frontiers in Immunology
Allergy
Immunology
Vaccine-Induced Immune Responses in Rodents and Nonhuman Primates by Use of a Humanized Human Immunodeficiency Virus Type 1 Pol Gene
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Immunotherapy in Prostate Cancer
The Bulletin of Urooncology
Suppression of Activin-Induced Apoptosis by Novel Antisense Strategy in Human Prostate Cancer Cells
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
A Glycolipid Adjuvant, 7dw8-5, Enhances CD8+ T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates
PLoS ONE
Multidisciplinary
5T4 Oncofoetal Glycoprotein: An Old Target for a Novel Prostate Cancer Immunotherapy
Oncotarget
Oncology
Novel Non-Nucleotidic STING Agonists for Cancer Immunotherapy
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology